Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07059962 · ClinicalTrials.gov registry record
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
A clinical trial of Kidney Disease and End Stage Kidney Disease (ESRD), sponsored by Bodyport.
- Recruiting
- Registry status
- 125
- Enrollment target
- 4
- Study locations
NCT07059962 is a study of Kidney Disease and End Stage Kidney Disease (ESRD) that is actively recruiting participants, run by Bodyport. The registered enrollment target is 125 participants, below the 2,934-participant average among 23 other Kidney Disease trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT07059962, a study of Kidney Disease and End Stage Kidney Disease (ESRD), is actively recruiting participants, sponsored by Bodyport.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 4
- Study locations
Study Summary
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Conditions Studied
Interventions
- DEVICE Bodyport Cardiac Scale
Study Locations (4)
California
- Desert Cities Dialysis - Victorville
Georgia
- Southeastern Clinical Research Institute - Augusta
Illinois
- Northwestern University - Chicago
Manitoba
- Seven Oaks General Hospital - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07059962
The ClinicalTrials.gov registry entry for NCT07059962 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,934-participant average among 23 other Kidney Disease trials with a reported enrollment target (96% lower). The listed sponsor is Bodyport, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Bodyport Cardiac Scale is the first listed.
NCT07059962 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT07059962 about?
NCT07059962 is a clinical study titled "Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)". To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
What is the current status of trial NCT07059962?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2025-09-09. Estimated completion is 2026-06.
What conditions does trial NCT07059962 study?
This clinical trial studies the following conditions: Kidney Disease, End Stage Kidney Disease (ESRD), Peritoneal Dialysis (PD).
What interventions are being tested in trial NCT07059962?
The interventions under investigation include: Bodyport Cardiac Scale (DEVICE).
Who is sponsoring clinical trial NCT07059962?
This trial is sponsored by Bodyport, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07059962 being conducted?
This trial has 4 study locations across California, Georgia, Illinois, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
-
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
RECRUITING · Phase 3
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Inspire HER: Inspiring the Heart and Emotions for Radical Health
RECRUITING · NA
-
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.